The SELCoH team are working in collaboration with other research teams and centres here at Kings College London as well as other Universities. The summaries of some of the collaborators for Phase 3 of SELCoH are detailed below:
NIHR and Wellcome Trust King's Clinical Research Facility
The Clinical Research Facility (CRF) is a specialist unit for clinical research within King’s College Hospital, South London and Maudsley (SLaM), King’s College London, and Guy’s and St Thomas’ NHS Trust. King’s College Hospital NHS Foundation Trust is part of King’s Health Partners Academic Health Sciences Centre (AHSC), a pioneering collaboration between King’s College London, and Guy’s and St Thomas’, King’s College Hospital and South London and Maudsley NHS Foundation Trusts. The CRF comprises the following sub units: Clinical Trials Facility (CTF), Experimental Medicine Unit (EMF) (which includes the MRI suite), & the Cell Therapy Unit (CTU).
We are collecting data for Phase 3 of SELCoH at the CRF. The blood samples, which are vital to the aims of Phase 3 are collected by trained research nurses employed by the CRF.
For more information about the CRF please contact:
Elka Giemza, CRF Manager
NIHR Mental Health BioResource
A BioResource is a large bank of biological (e.g. blood), clinical (e.g. medical records) and neuroimaging information (e.g. brain scans) that is usually used for scientific/medical research.
The purpose of the NIHR Mental Health BioResource is to facilitate research that aims to improve our understanding of different mental illnesses and identify new and better treatments for neurological and psychiatric disorders.
Our aim is to bring together groups of healthy volunteers, patients and relatives who have agreed to be contacted and can be invited to participate in relevant clinical research. Data collected from this research forms a valuable resource that can support research across the different centres.
The SELCoH Team is working with the BioResource for the safe storage and analysis of the blood samples collected in Phase 3.
Learn more about the NIHR BioResource for Mental Health